Have a symptom?
See what questions
a doctor would ask.
News » New mesothelioma drug shows promising results in mice

New mesothelioma drug shows promising results in mice

Solbec Pharmaceuticals Ltd claims that itís newly developed drug, Coramsine, is an effective treatment for asbestos-related cancer. Asbestos is responsible for up to 80% of mesothelioma cases. A study on mice found it was capable of treating and preventing mesothelioma and when used with CpG (immune triggering compound) it put the cancer into remission. The next step is to conduct human trials.

Source: summary of medical news story as reported by National Nine News

Related Disease Topics:

Article Source Details

About: New mesothelioma drug shows promising results in mice

Date: 23 November 2004

Source: National Nine News


Related Medical Topics

This summary article refers to the following medical categories:

More News Topics

  • Obesity is associated with an increased risk of many conditions
  • Obesity is the cause of surging diabetes figures
  • Obesity leads to liver disease
  • Obesity linked to esophageal precancerous condition
  • Obesity linked to reflux diseases and esophageal cancer
  • Obesity shows no signs of abating
  • Obesity surgery carries risks
  • Obstetrician cleared of negligence in cerebral palsy case
  • Obstetrician sued for cerebral palsy baby in historic settlement
  • Obstetrician suspended for a year and another doctor reprimanded for misdiagnosis
  • Obstetrics and litigation backlash
  • Occupational exposure to asbestos results in death

    By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

    Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise